ESR1 and colorectal carcinoma: For example, Norkin et al. employed CRC organoids to evaluate the efficacy of several drug classes not previously reported for CRC treatment, including antipsychotic phenothiazines, cholesterol-lowering statins, antimycotic conazoles, selective estrogen receptor modulators, and antihistamines.